Church & Dwight (NYSE:CHD) Now Covered by TD Cowen

TD Cowen assumed coverage on shares of Church & Dwight (NYSE:CHD) in a report released on Tuesday, MarketBeat Ratings reports. The firm set a “buy” rating and a $116.00 price target on the stock. TD Cowen’s price objective would suggest a potential upside of 15.60% from the company’s previous close.

Several other equities research analysts have also recently commented on CHD. JPMorgan Chase & Co. boosted their price target on shares of Church & Dwight from $97.00 to $101.00 and gave the stock an “underweight” rating in a research report on Monday. Evercore ISI boosted their price target on shares of Church & Dwight from $107.00 to $110.00 and gave the stock an “in-line” rating in a research report on Friday, May 3rd. Bank of America boosted their price target on shares of Church & Dwight from $100.00 to $104.00 and gave the stock a “neutral” rating in a research report on Monday, April 15th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Church & Dwight from $109.00 to $112.00 and gave the stock a “buy” rating in a research note on Monday, April 22nd. Finally, Barclays lowered their price objective on shares of Church & Dwight from $82.00 to $80.00 and set an “underweight” rating on the stock in a research note on Friday, July 19th. Three analysts have rated the stock with a sell rating, ten have assigned a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat, Church & Dwight presently has an average rating of “Hold” and a consensus price target of $107.28.

Church & Dwight Trading Up 0.1 %

CHD opened at $100.35 on Tuesday. The firm’s fifty day simple moving average is $105.65 and its 200 day simple moving average is $103.27. The company has a current ratio of 1.33, a quick ratio of 0.82 and a debt-to-equity ratio of 0.54. Church & Dwight has a 12 month low of $82.25 and a 12 month high of $110.31. The stock has a market capitalization of $24.54 billion, a P/E ratio of 31.86, a P/E/G ratio of 3.28 and a beta of 0.52.

Church & Dwight (NYSE:CHD) last issued its quarterly earnings results on Thursday, May 2nd. The company reported $0.96 EPS for the quarter, topping the consensus estimate of $0.86 by $0.10. Church & Dwight had a net margin of 13.13% and a return on equity of 20.35%. The firm had revenue of $1.50 billion for the quarter, compared to analysts’ expectations of $1.49 billion. During the same period in the previous year, the firm posted $0.85 EPS. The company’s revenue for the quarter was up 5.1% on a year-over-year basis. As a group, research analysts anticipate that Church & Dwight will post 3.46 EPS for the current fiscal year.

Insider Activity at Church & Dwight

In other news, Director Penry W. Price sold 7,752 shares of the firm’s stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $105.47, for a total transaction of $817,603.44. Following the transaction, the director now directly owns 25,692 shares of the company’s stock, valued at $2,709,735.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, Director Penry W. Price sold 7,752 shares of the firm’s stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $105.47, for a total transaction of $817,603.44. Following the transaction, the director now directly owns 25,692 shares of the company’s stock, valued at $2,709,735.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Ravichandra Krishnamu Saligram sold 20,000 shares of the firm’s stock in a transaction that occurred on Tuesday, June 4th. The stock was sold at an average price of $107.67, for a total transaction of $2,153,400.00. Following the transaction, the director now directly owns 13,793 shares in the company, valued at $1,485,092.31. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 182,346 shares of company stock worth $19,465,948. Insiders own 2.00% of the company’s stock.

Institutional Trading of Church & Dwight

Large investors have recently made changes to their positions in the company. Game Plan Financial Advisors LLC acquired a new stake in shares of Church & Dwight during the 1st quarter worth approximately $26,000. Crewe Advisors LLC acquired a new stake in Church & Dwight in the first quarter valued at approximately $28,000. Chilton Capital Management LLC boosted its position in Church & Dwight by 50.0% in the fourth quarter. Chilton Capital Management LLC now owns 330 shares of the company’s stock valued at $31,000 after buying an additional 110 shares in the last quarter. Roble Belko & Company Inc acquired a new stake in Church & Dwight in the first quarter valued at approximately $31,000. Finally, Creekmur Asset Management LLC acquired a new stake in Church & Dwight in the fourth quarter valued at approximately $32,000. Institutional investors and hedge funds own 86.60% of the company’s stock.

About Church & Dwight

Church & Dwight Co, Inc develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and showerheads under the WATERPIK brand; cold shortening and relief products under the ZICAM brand; oral care products under the THERABREATH brand; and acne treatment products under the HERO brand.